KURTARAN, B. Et Al. 2019. Efficacy and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey. EASL International Liver Congress,10-14 April 2019, Vienna-Austria .

KURTARAN, B., SARIGÜL, F., ÇABALAK, M., KAYA, S., SARI, N., KARSEN, H., ... ZERDALİ, E.(2019). Efficacy and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey . EASL International Liver Congress,10-14 April 2019, Vienna-Austria

KURTARAN, BEHİCE Et Al. "Efficacy and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey," EASL International Liver Congress,10-14 April 2019, Vienna-Austria, 2019

KURTARAN, BEHİCE Et Al. "Efficacy and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey." EASL International Liver Congress,10-14 April 2019, Vienna-Austria , 2019

KURTARAN, B. Et Al. (2019) . "Efficacy and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey." EASL International Liver Congress,10-14 April 2019, Vienna-Austria .

@conferencepaper{conferencepaper, author={BEHİCE KURTARAN Et Al. }, title={Efficacy and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey}, congress name={EASL International Liver Congress,10-14 April 2019, Vienna-Austria}, city={}, country={}, year={2019}}